Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma.-Reference-Cited by-同舟云学术

Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma.

Published:1993-06-05 Issue:6891 Volume:306 Page:1514-1518
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Gibson P,Henry D,Francis L,Cruickshank D,Dupen F,Higginbotham N,Henry R,Sutherland D

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference21 articles.

1. Non-prescription sale of inhaled metaproterenol -dejavu;Hendeles, L.; Weinberger, M.,1984

2. Pressure to ease POM status in UK;SCRIP,1991

3. Non-prescription drug approval: therapeutic strategy or marketing decision?;McLeod, D.C.;Annals ofPharmnacotherapy,1989

4. Pharmacists' evaluations of the nonprescription availability of metaproterenol, cimetidine, ibuprofen, and nystatin;Madhavan, S.; Schondelmeyer, S.W.;Am7Hosp Pharm,1989

5. Over the counter drugs. The issues;Cranz, H.;Drug Safety,1990

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National expert consensus on short-acting beta ₂ -agonist overreliance in asthma care in Malaysia;Journal of Asthma;2024-07

2. Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil;Jornal Brasileiro de Pneumologia;2024-01-17

3. Over-the-counter use of short-acting beta-2 agonists: a systematic review;Journal of Pharmaceutical Policy and Practice;2023-10-09

4. Over-prescription of short-acting β2-agonists remains a serious health concern in Kenya: results from the SABINA III study;BMC Primary Care;2023-07-08

5. Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study;African Journal of Thoracic and Critical Care Medicine;2022-12-19